Physiological aspects of vaginal contraception.
D002465:Cell Movement / Q000187:drug effects; D002614:Chelating Agents / Q000494:pharmacology; D003271:Contraceptive Agents, Female / Q000627:therapeutic use; D004573:Electrolytes; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy; D013078:Sperm Immobilizing Agents / Q000494:pharmacology*; D013089:Spermatocidal Agents / Q000494:pharmacology*; D013094:Spermatozoa / Q000187:drug effects*; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology; D013997:Time Factors; D014508:Urea / Q000494:pharmacology; D014621:Vagina
D002614:Chelating Agents; D003271:Contraceptive Agents, Female; D004573:Electrolytes; D004791:Enzyme Inhibitors; D013078:Sperm Immobilizing Agents; D013089:Spermatocidal Agents; D013439:Sulfhydryl Reagents; D013501:Surface-Active Agents; D014508:Urea